NCT02933229View on ClinicalTrials.gov

The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

October 31, 2031

Study Completion Date

October 31, 2031

Conditions
Helicobacter Pylorithe Operative Link on Gastric Intestinal MetaplasiaOperative Link on Gastric Intestinal Assessment
Interventions
DEVICE

biopsy

patients enrolled in the study will receive gastroscopy and biopsies in order to evaluate status of pathology.

DRUG

H. pylori eradication

"H. pylori eradication therapy comprising esomeprazole, amoxicillin,clarithromycin and colloidal bismuth pectin.~If failed in eradicating H. pylori, a culture based antimicrobial susceptibility test will be used to guide H. pylori eradication."

Trial Locations (1)

250012

Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan

All Listed Sponsors
lead

Shandong University

OTHER